One of the world’s biggest vaccine proponents and strident defender of intellectual property rights is funding, directly and indirectly, large trials into cheap, off-patent, off-label COVID-19 treatments, including ivermectin.More
A Worrying Trend Emerges in South America, As Right-Wing Populists Take A Leaf Out of Trump and Netanyahu’s Playbook
If the elected leaders of long-established democracies like the US and Israel can question the workings of their electoral system, why can’t others of less-established ones? More
HSBC in Big Trouble in its Biggest Market, China
As HSBC pivots further to Asia and away from the West, its business in China gets more and more complicated.More
Tourism Begins to Recover in Europe, But Is It Just a Dead Cat Bounce?
Warning signs are already flashing that the reopening of Europe’s tourism industry may be short lived.More
Two UK Commercial Real Estate Funds Shut Permanently, Investors Trapped, as Sector-Wide Exodus Intensifies
The sector was already hit hard by Brexit, then by lockdowns, and now by working from home as companies plan to cut floor space.More
Is Another Military Coup Brewing in Peru, After Historic Electoral Victory for Leftist Candidate?
The threat should not be taken lightly, especially given Peru’s long history of coups d’états.More
First UK Inquiry Into Greensill Scandal Calls for Extension to Lobbying Ban for Former Ministers and Civil Servants
The inquiry also recommends greater transparency and accountability from the government. Unfortunately, the trend is in the opposite direction.More
WHO Celebrates As Indian Health Regulator Removes Ivermectin from Its Covid-19 Protocol
After India finally gets somewhat of a grip on its deadly second wave, one of its health regulators just took away one of its main lines of defense. More
The Empire Strikes Back Against Mexican President AMLO
The Economist urges Mexican voters to vote for anyone but AMLO and the US government is up to its old tricks: funneling money to political opposition groups.More
Bank of England Chief Economist: Avoid Inflation Surge “Like the Plague”
“An upside surprise to inflation is among the greatest risks”; we’d need “to tighten policy even more rapidly or on a more significant scale, or possibly both, in a way that would take the legs out of the recovery.”More
Nick Corbishley 